Ad
related to: pseudoephedrine diversion australia today news headlines
Search results
Results from the WOW.Com Content Network
Pseudoephedrine, sold under the brand name Sudafedamong others, is a sympathomimeticmedicationwhich is used as a decongestantto treat nasal congestion. [1][13][2]It has also been used off-labelfor certain other indications, like treatment of low blood pressure.
S3R drugs are those that may have an increased risk of illegal diversion or abuse. These are specified in Clause 23 of the Poisons and Therapeutic Goods Regulation 2002 (NSW). As of January 2006, all pseudoephedrine-containing preparations are S3R. Rikodeine cough syrup also falls into category which contains Dihydrocodeine and Sorbitol.
Precursor chemicals. Appearance. Drug precursors, also referred to as precursor chemicals or simply precursors, are substances used to manufacture illicit drugs. Most precursors also have legitimate commercial uses and are legally used in a wide variety of industrial processes and consumer products, such as medicines, flavourings, and fragrances.
(Reuters) - The European Medicines Agency's (EMA) safety committee on Friday recommended changes to product information for all medicines that contain the ingredient pseudoephedrine to address ...
The illegal drug trade in China is influenced by factors such as history, location, size, population, and current economic conditions. China has one-sixth of the world's population and a large and expanding economy. China's large land mass, close proximity to the Golden Triangle, Golden Crescent, and numerous coastal cities with large and ...
Ephedrine is a central nervous system (CNS) stimulant and sympathomimetic agent that is often used to prevent low blood pressure during anesthesia. [ 11 ] It has also been used for asthma, narcolepsy, and obesity but is not the preferred treatment. [ 11 ] It is of unclear benefit in nasal congestion. [ 11 ]
National Precursor Log Exchange. The National Precursor Log Exchange (NPLEx) is a real-time electronic logging system which tracks sales of the methamphetamine precursors ephedrine and pseudoephedrine in the United States. The program is operated by the National Association of Drug Diversion Investigators (NADDI), funded by manufacturers of ...
Signed into law by President George W. Bush on March 9, 2006. The Combat Methamphetamine Epidemic Act of 2005 (CMEA) is federal legislation enacted in the United States on March 9, 2006, to regulate, among other things, retail over-the-counter sales of following products because of their use in the manufacture of illegal drugs: ephedrine.
Ad
related to: pseudoephedrine diversion australia today news headlines